Industry effects on evidence: a case study of long-acting injectable antipsychotics

References

• Adams, C. E., M. K. P. Fenton, S. Quraishi, and A. S. David. 2001. “Systematic meta-review of Depot Antipsychotic Drugs for People with Schizophrenia.” The British Journal of Psychiatry 179 (4): 290–299. doi:10.1192/bjp.179.4.290.
   PubMedGoogle Scholar
• Andreas, L., J. Lexchin, B. Mintzes, J. B. Schroll, and L. Bero. 2017. “Industry Sponsorship and Research Outcome.” Cochrane Database of Systematic Reviews 2. doi:10.1002/14651858.MR000033.pub3.
   Google Scholar
• Bellack, A. S. 2006. “Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications.” Schizophrenia Bulletin 32 (3): 432–442. doi:10.1093/schbul/sbj044.
   PubMed Web of Science ®Google Scholar
• Bero, L., N. Chartres, J. Diong, A. Fabbri, D. Ghersi, J. Lam, A. Lau, et al. 2018. “The Risk of Bias in Observational Studies of Exposures (ROBINS-E) Tool: Concerns Arising from Application to Observational Studies of Exposures.” Systematic Reviews 7 (1): 1–11. DOI:10.1186/s13643-018-0915-2.
   PubMedGoogle Scholar
• Boutron, I., M. J. Page, J. P. T. Higgins, D. G. Altman, A. Lundh, A. Hróbjartsson, and Cochrane Bias Methods Group. 2019. “Considering Bias and Conflicts of Interest among the Included Studies.” Cochrane Handbook for Systematic Reviews of Interventions 177–204.
   Google Scholar
• Business Wire. 2020. “LB Pharmaceuticals Inc Secures $10.0 Million in Additional Financing.” Business Wire, September 25. https://www.businesswire.com/news/home/20200925005207/en/LB-Pharmaceuticals-Inc-Secures-10.0-Million-in-Addition
   Google Scholar
• “Cochrane’s revised Conflict of Interest Policy for Cochrane Library Content will take effect in October 2020.” 2020. https://community.cochrane.org/news/cochranes-revised-conflict-interest-policy-cochrane-library-content-will-take-effect-october-2020
   Google Scholar
• Cohen, A. N., A. B. Hamilton, E. R. Saks, D. L. Glover, S. M. Glynn, J. S. Brekke, and S. R. Marder. 2017. “How Occupationally high-achieving Individuals with a Diagnosis of Schizophrenia Manage Their Symptoms.” Psychiatric Services 68 (4): 324–329. doi:10.1176/appi.ps.201600031.
   PubMed Web of Science ®Google Scholar
• Corrigan, P. W., D. Giffort, F. Rashid, M. Leary, and I. Okeke. 1999. “Recovery as a Psychological Construct.” Community Mental Health Journal 35 (3): 231–239. doi:10.1023/A:1018741302682.
   PubMed Web of Science ®Google Scholar
• Cosgrove, L, B. Mintzes, H. J. Bursztajn, and A. F. Shaughnessy. 2021. “Long-acting Antipsychotics: Is What We Know Really So?” The Lancet Psychiatry 8 (8): 651. doi:10.1016/S2215-0366(21)00237-6.
   PubMed Web of Science ®Google Scholar
• Djulbegovic, B., A. Cantor, and M. Clarke. 2003. “The Importance of the Preservation of the Ethical Principle of Equipoise in the Design of Clinical Trials: Relative Impact of the Methodological Quality Domains on the Treatment Effect in Randomized Controlled Trials.” Accountability in Research: Policies and Quality Assurance 10 (4): 301–315. doi:10.1080/714906103.
   PubMedGoogle Scholar
• Drapalski, A. L., D. Medoff, G. J. Unick, D. I. Velligan, L. B. Dixon, and A. S. Bellack. 2012. “Assessing Recovery of People with Serious Mental Illness: Development of a New Scale.” Psychiatric Services 63 (1): 48–53. doi:10.1176/appi.ps.201100109.
   PubMed Web of Science ®Google Scholar
• Frances, A. 2016. “Setting the Record Straight on Antipsychotics.” Psychiatric Times 33 (9): 16–18. https://www.psychiatrictimes.com/view/setting-record-straight-antipsychotics
   PubMedGoogle Scholar
• Guyatt, G., A. D. Oxman, E. A. Akl, R. Kunz, G. Vist, J. Brozek, S. Norris, et al. 2011. “GRADE Guidelines: 1. Introduction—GRADE Evidence Profiles and Summary of Findings Tables.” Journal of Clinical Epidemiology 64 (4): 383–394. DOI:10.1016/j.jclinepi.2010.04.026.
   PubMed Web of Science ®Google Scholar
• Hansen, C., A. Lundh, K. Rasmussen, and A. Hróbjartsson. 2019. “Financial Conflicts of Interest in Systematic Reviews: Associations with Results, Conclusions, and Methodological Quality.” Cochrane Database of Systematic Reviews 8. doi:10.1002/14651858.MR000047.pub2.
   PubMedGoogle Scholar
• Institute of Medicine (US). 2009. Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of Interest in Medical Research, Education, and Practice. B. Lo and M. J. Fieldeditors. Washington (DC): National Academies Press (US).
   Google Scholar
• Ioannidis, J. P. A. 2005. “Why Most Published Research Findings are False.” PLoS Medicine 2 (8): 124. doi:10.1371/journal.pmed.0020124.
   PubMed Web of Science ®Google Scholar
• Jones, N., and M. Shattell. 2016. “Not What the Textbooks Describe: Challenging Clinical Conventions about Psychosis.” Issues in Mental Health Nursing 37 (10): 769–772. doi:10.1080/01612840.2016.1180725.
   PubMed Web of Science ®Google Scholar
• Kafaee, M., M. Taghi Kheirkhah, R. Balali, and S. Gharibzadeh. 2021. “Conflict of Interest as a Cognitive Bias.” Accountability in Research 1–18. doi:10.1080/08989621.2021.1938556.
   Google Scholar
• Kim, B., S.-H. Lee, Y. Kuang Yang, J.-I. Park, and Y.-C. Chung. 2012. “Long-acting Injectable Antipsychotics for first-episode Schizophrenia: The Pros and Cons.” Schizophrenia Research and Treatment 2012: 1–8. doi:10.1155/2012/560836.
   Google Scholar
• Lessig, L. 2013. “‘Institutional Corruption’ Defined.” The Journal of Law, Medicine & Ethics 41 (3): 553–555. doi:10.1111/jlme.12063.
   PubMed Web of Science ®Google Scholar
• Leucht, C., S. Heres, J. M. Kane, W. Kissling, J. M. Davis, and S. Leucht. 2011. “Oral versus Depot Antipsychotic Drugs for schizophrenia—A Critical Systematic Review and meta-analysis of Randomised long-term Trials.” Schizophrenia Research 127 (1–3): 83–92. doi:10.1016/j.schres.2010.11.020.
   PubMed Web of Science ®Google Scholar
• Lexchin, J., and O. O’Donovan. 2010. “Prohibiting or ‘Managing’ Conflict of Interest? A Review of Policies and Procedures in Three European Drug Regulation Agencies.” Social Science & Medicine 70 (5): 643–647. doi:10.1016/j.socscimed.2009.09.002.
   PubMed Web of Science ®Google Scholar
• Liberman, R. P., and A. Kopelowicz. 2005. “Recovery from Schizophrenia: A Concept in Search of Research.” Psychiatric Services 56 (6): 735–742. doi:10.1176/appi.ps.56.6.735.
   PubMed Web of Science ®Google Scholar
• Lisa, C., F. Herrawi, and A. F. Shaughnessy. 2021. “Conflicts of Interest in Psychopharmacology Textbooks.” Community Mental Health Journal 58 (8): 619–623. doi:10.1007/s10597-021-00906-6.
   PubMedGoogle Scholar
• Lukens, J. M., and P. Solomon. 2013. “Thinking through Recovery: Resolving Ethical Challenges and Promoting Social Work Values in Mental Health Services.” Journal of Social Work Values and Ethics 10 (1): 61–71.
   Google Scholar
• McKenzie, J. E., S. E. Brennan, R. E. Ryan, H. J. Thomson, R. V. Johnston, and J. Thomas. 2019. “Defining the Criteria for Including Studies and How They Will Be Grouped for the Synthesis.” Cochrane Handbook for Systematic Reviews of Interventions 33–65.
   Google Scholar
• mhGAP. 2015. “Role of Depot Antipsychotic Medication in long-term Antipsychotic Treatment.” https://www.who.int/mental_health/mhgap/evidence/resource/psychosis_q5.pdf?ua=1
   Google Scholar
• Montori, V. M., D. Allwood, and A. Fog Heen. 2021. “A Moratorium on Strong Recommendations Is Needed.” BMJ 375 (n2887).
   Google Scholar
• Open Payments. (nd). “Open Payments Data.” https://openpaymentsdata.cms.gov/
   Google Scholar
• Page, M. J., J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, et al. 2021. “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.” BMJ. 372.
   Google Scholar
• Ralph, R. O., K. Kidder, and D. Phillips. 2000. Can We Measure Recovery?: A Compendium of Recovery and recovery-related Instruments. Cambridge, Mass: Evaluation Center@HRSI.
   Google Scholar
• Rodwin, M. A. 2018. “Attempts to Redefine Conflicts of Interest.” Accountability in Research 25 (2): 67–78. doi:10.1080/08989621.2017.1405728.
   PubMed Web of Science ®Google Scholar
• Scott, I. A., and G. H. Guyatt. 2014. “Suggestions for Improving Guideline Utility and Trustworthiness.” Evidence Based Medicine 19 (2): 41–46. doi:10.1136/eb-2013-101634.
   PubMedGoogle Scholar
• Sismondo, S. 2021. “Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science.” Frontiers in Research Metrics and Analytics 6: 2. doi:10.3389/frma.2021.614013.
   Google Scholar
• Stegenga, J. 2011. “Is meta-analysis the Platinum Standard of Evidence?” Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 42 (4): 497–507. doi:10.1016/j.shpsc.2011.07.003.
   PubMedGoogle Scholar
• Taishiro, K., K. Hagi, S. Kurokawa, J. M. Kane, and C. U. Correll. 2021. “Long-acting Injectable versus Oral Antipsychotics for the Maintenance Treatment of Schizophrenia: A Systematic Review and Comparative meta-analysis of Randomised, Cohort, and pre–post Studies.” The Lancet Psychiatry 8 (5): 387–404. doi:10.1016/S2215-0366(21)00039-0.
   PubMed Web of Science ®Google Scholar
• Thompson, D. F. 2009. “The Challenge of Conflict of Interest in Medicine.” Zeitschrift Fuer Evidenz, Fortbildung Und Qualitaet Im Gesundheitswesen 103 (3): 136–140. doi:10.1016/j.zefq.2009.02.021.
   PubMedGoogle Scholar
• Tigas, M., R. Grochowski Jones, C. Ornstein, and L. Groeger. 2019. “Dollars for Docs.” ProPublica. https://projects.propublica.org/docdollars/
   Google Scholar
• Veronica, Y., D. Rennie, and L. A. Bero. 2007. “Financial Ties and Concordance between Results and Conclusions in meta-analyses: Retrospective Cohort Study.” BMJ 335 (7631): 1202–1205. doi:10.1136/bmj.39376.447211.BE.
   PubMedGoogle Scholar
• Yao, L., G. H. Guyatt, and B. Djulbegovic. 2021. “Can We Trust Strong Recommendations Based on Low Quality Evidence?” BMJ 375 (n2833).
   Google Scholar
• Yao, L., M. Muneeb Ahmed, G. H. Guyatt, P. Yan, X. Hui, Q. Wang, K. Yang, J. Tian, and B. Djulbegovic. 2021. “Discordant and Inappropriate Discordant Recommendations in Consensus and Evidence Based Guidelines: Empirical Analysis.” BMJ 375: e066045. doi:10.1136/bmj-2021-066045.
   PubMedGoogle Scholar
• Young, S. N. 2009. “Bias in the Research Literature and Conflict of Interest: An Issue for Publishers, Editors, Reviewers and Authors, and It Is Not Just about the Money.” Journal of Psychiatry & Neuroscience: JPN 34 (6): 412.
   PubMed Web of Science ®Google Scholar